Stock Fundamentals

Company Information

▼
Company Name
Adaptimmune Therapeutics Plc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US00653A1079
CIK: 0001621227
CUSIP: 00653A107
Currency: USD
Full Time Employees: 506
Phone: 44 12 3543 0000
Website: https://www.adaptimmune.com
Fiscal Year End: December
IPO Date: May 06, 2015
Description:

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Address:

60 Jubilee Avenue, Abingdon, United Kingdom, OX14 4RX

Directors & Officers

▼
Name Title Year Born
Mr. Adrian G. Rawcliffe CEO & Director 1972
Mr. William Charles A. Bertrand Jr., Esq., J.D. COO, Chief Compliance Officer & Secretary 1965
Dr. Helen Katrina Tayton-Martin MBA, Ph.D. Co-Founder 1967
Mr. Christopher James Hill ACA, BA (Hons) Chief Financial Officer 1980
Dr. Juli P. Miller Ph.D. VP of Corporate Affairs & Investor Relations NA
Ms. Kerry Sharp Senior VP & General Counsel NA
Ms. Dana Lynch Senior Director of Corporate Communications NA
Ms. Kimberly Freeman Vice President of Commercial Planning NA
Laura Gunn Vice President of Medical Affairs NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
EcoR1 Capital, LLC 27.40M Jun 30, 2025 10.34% $0.39 0.00%
Long Focus Capital Management, LLC 23.76M Jun 30, 2025 8.96% $0.22 0.00%
Two Seas Capital LP 22.58M Jun 30, 2025 8.52% $0.09 9.99%
NEA Management Company, LLC 17.08M Jun 30, 2025 6.44% $0.31 0.00%
Mpm Asset Management, LLC 4.81M Jun 30, 2025 1.81% $2.66 -9.86%
MPM Oncology Impact Management LP 4.41M Jun 30, 2025 1.66% $0.18 -9.86%
Morgan Stanley - Brokerage Accounts 4.23M Jun 30, 2025 1.60% $0.00 55.83%
Rock Springs Capital Management LP 2.48M Jun 30, 2025 0.94% $0.04 0.00%
Renaissance Technologies Corp 1.88M Jun 30, 2025 0.71% $0.00 3.80%
Bank of America Corp 1.14M Jun 30, 2025 0.43% $0.00 -0.46%
Empirical Finance, LLC 800.00K Jun 30, 2025 0.30% $0.01 0.00%
FMR Inc 464.28K Jun 30, 2025 0.18% $0.00 -73.54%
Rathbone Brothers PLC 432.82K Jun 30, 2025 0.16% $0.00 0.00%
State Street Corp 426.71K Jun 30, 2025 0.16% $0.00 1.29%
BlackRock Inc 179.09K Jun 30, 2025 0.07% $0.00 -2.50%
Key Client Fiduciary Advisors, LLC 175.56K Jun 30, 2025 0.07% $0.02 16.92%
Clear Harbor Asset Management, LLC 145.40K Jun 30, 2025 0.05% $0.00 -39.60%
Almitas Capital LLC 109.05K Jun 30, 2025 0.04% $0.01 0.00%
Advisor Group Holdings, Inc. 90.06K Jun 30, 2025 0.03% $0.00 38.43%
XTX Topco Ltd 80.02K Jun 30, 2025 0.03% $0.00 0.00%

Shares Statistics

▼
Shares Outstanding: 265.05M
Shares Float: 1.22B
% Insiders: 63.10%
% Institutions: 3,123.30%
Short % Float: 14.34%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 EcoR1 Capital, LLC 27.40M 10.34% ▲ 0.00% Jun 30, 2025
2 Long Focus Capital Management, LLC 23.76M 8.96% ▲ 0.00% Jun 30, 2025
3 Two Seas Capital LP 22.58M 8.52% ▲ 9.99% Jun 30, 2025
4 NEA Management Company, LLC 17.08M 6.44% ▲ 0.00% Jun 30, 2025
5 Mpm Asset Management, LLC 4.81M 1.81% ▼ 9.86% Jun 30, 2025
6 MPM Oncology Impact Management LP 4.41M 1.66% ▼ 9.86% Jun 30, 2025
7 Morgan Stanley - Brokerage Accounts 4.23M 1.60% ▲ 55.83% Jun 30, 2025
8 Rock Springs Capital Management LP 2.48M 0.94% ▲ 0.00% Jun 30, 2025
9 Renaissance Technologies Corp 1.88M 0.71% ▲ 3.80% Jun 30, 2025
10 Bank of America Corp 1.14M 0.43% ▼ 0.46% Jun 30, 2025

Valuation Metrics

▼
Enterprise Value: $31.98M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $14.55M
EBITDA: $-137.24M
PEG Ratio: $0.11
Book Value: $-0.27
Earnings/Share: $-0.66
Profit Margin: -260.82%
Operating Margin: -221.45%
ROA (TTM): -40.86%
ROE (TTM): -1,341.10%
Revenue (TTM): $65.09M
Revenue/Share (TTM): $0.25
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -89.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 2.92x 5.03x 0.95x -20.54x -1.13x
2023-12-31 2.85x 0.14x 0.86x N/A -0.04x
2022-12-31 3.96x 0.07x 0.75x -162.99x -0.04x
2021-12-31 6.64x 0.02x 0.56x -32.80x -0.03x
2020-12-31 10.19x 0.01x 0.24x -38.39x -0.02x
2019-12-31 3.51x 0.02x 0.32x -49.09x -0.02x
2018-12-31 9.46x 0.00x 0.11x -219.06x 0.00x
2017-12-31 3.10x 0.00x 0.28x -36.17x 0.00x
2016-12-31 4.94x 0.10x 0.29x N/A -0.24x
2015-12-31 11.03x 0.10x 0.14x -45.39x -1.11x
2014-12-31 11.03x 0.10x 0.14x -45.39x -1.21x
2013-12-31 1.02x 0.00x 0.96x -2,109.50x 0.00x
2012-12-31 0.40x -19.29x 2.19x -1,372.48x -3.69x
2011-12-31 0.95x -12.23x 1.03x N/A N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 02, 2025 Gavin Wood N/A Sale 96.00K $0.01 $960.00
Aug 28, 2025 William C Bertrand Jr N/A Sale 207.00K $0.01 $2.07K
Aug 18, 2025 Ali Behbahani N/A Sale 14.67M $0.01 $146.72K
Aug 15, 2025 Ali Behbahani N/A Sale 4.83M $0.01 $48.28K
Jan 17, 2025 Elliot Norry N/A Sale 5.58K $0.58 $3.24K
Jan 15, 2025 Cintia Piccina N/A Sale 12.99K $0.57 $7.40K
Jan 15, 2025 William C Bertrand Jr N/A Sale 9.80K $0.57 $5.59K
Jan 13, 2025 Elliot Norry N/A Sale 12.39K $0.59 $7.31K
Jan 13, 2025 William C Bertrand Jr N/A Sale 9.74K $0.59 $5.75K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ADAP.US!